Atlas Brown’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,796
Closed -$361K 147
2019
Q2
$361K Sell
2,796
-19
-0.7% -$2.34K 0.25% 104
2019
Q1
$362K Sell
2,815
-66
-2% -$8.34K 0.26% 103
2018
Q4
$319K Buy
2,881
+101
+4% +$12.2K 0.25% 99
2018
Q3
$378K Sell
2,780
-25
-0.9% -$3.25K 0.23% 102
2018
Q2
$356K Sell
2,805
-91
-3% -$10.7K 0.08% 105
2018
Q1
$349K Buy
2,896
+162
+6% +$20.3K 0.06% 107
2017
Q4
$361K Buy
2,734
+47
+2% +$6K 0.06% 105
2017
Q3
$360K Sell
2,687
-88
-3% -$11.5K 0.08% 97
2017
Q2
$349K Sell
2,775
-12
-0.4% -$1.45K 0.31% 94
2017
Q1
$332K Sell
2,787
-121
-4% -$14.2K 0.26% 95
2016
Q4
$335K Hold
2,908
0.14% 91
2016
Q3
$335K Sell
2,908
-41
-1% -$4.67K 0.14% 91
2016
Q2
$302K Sell
2,949
-80
-3% -$8.53K 0.12% 96
2016
Q1
$314K Sell
3,029
-12
-0.4% -$1.25K 0.13% 94
2015
Q4
$317K Hold
3,041
0.2% 84
2015
Q3
$348K Hold
3,041
0.15% 77
2015
Q2
$415K Buy
3,041
+56
+2% +$7.44K 0.16% 71
2015
Q1
$387K Buy
+2,985
New +$375K 0.1% 74

Other funds holding BBH

Atlas Brown's BBH Position: Q3 2019 in Review

Atlas Brown sold out of VanEck Biotech ETF (BBH) in Q3 2019, closing a stake of 2,796 shares — an estimated $361K sold.

Atlas Brown first reported a position in BBH in Q1 2015 and held it in 18 quarters. The position peaked at $415K in Q2 2015. 78 funds tracked by Wall St. Rank hold BBH as of Q3 2019.

  • Atlas Brown reported no remaining VanEck Biotech ETF position as of Q3 2019 after selling out during the quarter.
  • Atlas Brown sold 2,796 VanEck Biotech ETF shares in Q3 2019, an estimated $361K.
  • Atlas Brown first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 18 quarters.
  • Atlas Brown's VanEck Biotech ETF position peaked at $415K in Q2 2015.
  • 78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2019.

Based on Atlas Brown's 13F filing for Q3 2019, filed 29 Oct 2019.